Group 1 - The core point of the announcement is the completion of the share reduction plan by major shareholders of Shanghai Aohua Endoscopy Co., Ltd, which involved a total reduction of 2,581,774 shares, accounting for 1.92% of the company's total share capital [1][2][3] - Prior to the reduction, the shareholders Suzhou Junlian Xinkang Venture Capital Partnership and Gaoshen Limited held 1,030,295 shares (0.77%) and 1,551,479 shares (1.15%) respectively, with a combined total of 2,581,774 shares (1.92%) [1][2] - The reduction was executed through both centralized bidding and block trading methods, with a maximum of 1,346,574 shares (1%) through centralized bidding and 1,235,200 shares (0.92%) through block trading [2] Group 2 - The reduction plan was disclosed on July 8, 2025, and the shareholders were required to fulfill commitments made during the company's IPO period [2] - As of October 13, 2025, the shareholders successfully completed the reduction plan within the specified time frame, confirming that the actual reduction matched the previously disclosed plan [2][3] - The announcement confirms that the reduction plan was not terminated early and was fully implemented as planned [3]
上海澳华内镜股份有限公司股东减持股份结果公告